Furthermore, another study showed that among 98 newly diagnosed NKTCL patients receiving asparaginase-based chemotherapy, those with high levels of IL-10 at diagnosis tended to have more adverse clinical features. Here, IL10 is linked to extranodal nasal NK/T cell lymphoma.